Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as valproic acid, work in different ways to stop
the growth of tumor cells, either by killing the cells or by stopping them from dividing.
Valproic acid may also stop the growth of solid tumors or CNS tumors by blocking blood flow
to the tumor.
PURPOSE: This phase I trial is studying the side effects and best dose of valproic acid in
treating patients with recurrent or refractory solid tumors or CNS tumors.